Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV004576799 | SCV005060538 | uncertain significance | Neuroblastoma, susceptibility to, 3 | 2023-11-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004634421 | SCV005121214 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-06-02 | criteria provided, single submitter | clinical testing | The p.G153C variant (also known as c.457G>T), located in coding exon 1 of the ALK gene, results from a G to T substitution at nucleotide position 457. The glycine at codon 153 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |